URGN News and Press, UroGen Pharma Ltd. From 02/24/24

2024-02-24 05:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

– Guggenheim 6th Annual Biotechnology Conference – – Oppenheimer 34th Annual Healthcare Life Sciences Conference – UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothel...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced the submission of the Chemistry, Manufacturing, and Controls (CMC) section of the New Drug Application (NDA) for UGN-102 (m...

UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today announced a licensing agreement with medac GmbH to develop a next-generation novel mitomycin-based formulation for urothelial cancers...

2024-01-12 06:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

- Fireside Chat January 18, 2024, at 12:00 pm ET - UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced that Liz Barrett, President and CEO, will participate in ...

2023-12-28 19:18:08 ET Summary JELMYTO provides growing but limited revenue for Urogen. Urogen's best shot at success for its shareholders depends on its UGN-102. Urogen has adequate financial resources to carry it to submission of UGN-102 as long as it encounters no delays. ...

2023-12-28 18:10:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2023-11-14 14:59:09 ET Urogen Pharma Ltd (URGN) Q3 2023 Earnings Conference Call November 14, 2023, 10:00 ET Company Participants Vincent Perrone - Senior Director, IR Elizabeth Barrett - President, CEO & Director Mark Schoenberg - Chief Medical Officer D...

2023-11-14 08:18:08 ET More on UroGen Pharma UroGen Pharma's Financial And Clinical Symbiosis Seeking Alpha’s Quant Rating on UroGen Pharma Historical earnings data for UroGen Pharma Financial information for UroGen Pharma For further details s...